Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
Adoptive T cell transfer for cancer immunotherapy in the era of synthetic biology.
复制标题
在合成生物学时代,用于癌症免疫疗法的过继T细胞转移。
DOI:
10.1016/j.immuni.2013.07.002
复制
发表时间:
2013-07-25
期刊:
影响因子:
32.4
通讯作者:
June CH
中科院分区:
文献类型:
--
作者:
Kalos M;June CH
Adoptive T cell transfer for cancer and chronic infection is an emerging field that shows promise in recent trials. Synthetic biology-based engineering of T lymphocytes to express high affinity antigen-receptors can overcome immune tolerance, which has been a major limitation of immunotherapy-based strategies. Advances in cell engineering and culture approaches to enable efficient gene transfer and ex vivo cell expansion have facilitated broader evaluation of this technology, moving adoptive transfer from a “boutique” application to the cusp of a mainstream technology. The major challenge currently facing the field is to increase the specificity of engineered T cells for tumors, since targeting shared antigens has the potential to lead to on-target off-tumor toxicities, as observed in recent trials. As the field of adoptive transfer technology matures, the major engineering challenge is the development of automated cell culture systems, so that the approach can extend beyond specialized academic centers and become widely available.
登录
查看更多内容
影响因子:
15.9
作者:
Berger, Carolina;Jensen, Michael C.;Riddell, Stanley R.
通讯作者:
Riddell, Stanley R.
影响因子:
17.1
作者:
Brentjens RJ;Davila ML;Riviere I;Park J;Wang X;Cowell LG;Bartido S;Stefanski J;Taylor C;Olszewska M;Borquez-Ojeda O;Qu J;Wasielewska T;He Q;Bernal Y;Rijo IV;Hedvat C;Kobos R;Curran K;Steinherz P;Jurcic J;Rosenblat T;Maslak P;Frattini M;Sadelain M
通讯作者:
Sadelain M
影响因子:
15.9
作者:
Baitsch, Lukas;Baumgaertner, Petra;Speiser, Daniel E.
通讯作者:
Speiser, Daniel E.
影响因子:
20.3
作者:
Bollard, CM;Rössig, C;Rooney, CM
通讯作者:
Rooney, CM
影响因子:
5.1
作者:
Eaton, D;Gilham, DE;Hawkins, RE
通讯作者:
Hawkins, RE